Saxagliptin hydrochloride is a potent, selective, reversible, competitive, and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with a Ki of 0.6-1.3 nM. It has potential for research into type 2 diabetes mellitus. It has been shown to induce β-cell proliferation, increase p-AKT and active β-catenin protein levels, and increase insulin secretion.
- Potent, selective, reversible, competitive, and orally active
- Inhibits dipeptidyl peptidase-4 (DPP-4) with a Ki of 0.6-1.3 nM
- Potential for type 2 diabetes mellitus research
- Induces β-cell proliferation
- Increases p-AKT and active β-catenin protein levels
- Increases insulin secretion and decreases glucagon secretion